NYSE:PBHPrestige Consumer Healthcare Stock Price, Forecast & News

Prestige Consumer Healthcare's stock was trading at $35.91 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, PBH shares have increased by 6.3% and is now trading at $38.16.
View which stocks have been most impacted by Coronavirus.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Prestige Consumer Healthcare in the last year. There are currently 6 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Prestige Consumer Healthcare.

Prestige Consumer Healthcare is scheduled to release its next quarterly earnings announcement on Thursday, October 29th 2020.
View our earnings forecast for Prestige Consumer Healthcare.

Prestige Consumer Healthcare Inc (NYSE:PBH) posted its earnings results on Thursday, August, 6th. The company reported $0.86 EPS for the quarter, topping analysts' consensus estimates of $0.70 by $0.16. The firm had revenue of $229.40 million for the quarter, compared to analyst estimates of $221.27 million. Prestige Consumer Healthcare had a net margin of 15.84% and a return on equity of 13.81%. The business's revenue for the quarter was down 1.2% on a year-over-year basis. During the same period last year, the business posted $0.65 earnings per share.
View Prestige Consumer Healthcare's earnings history.

Prestige Consumer Healthcare issued an update on its second quarter earnings guidance on Thursday, August, 6th. The company provided earnings per share (EPS) guidance of $0.70 or more for the period, compared to the Thomson Reuters consensus estimate of $0.71. The company issued revenue guidance of $225 million or more, compared to the consensus revenue estimate of $236.06 million.

7 Wall Street analysts have issued 1-year price objectives for Prestige Consumer Healthcare's stock. Their forecasts range from $43.00 to $97.00. On average, they expect Prestige Consumer Healthcare's stock price to reach $69.00 in the next twelve months. This suggests a possible upside of 80.8% from the stock's current price.
View analysts' price targets for Prestige Consumer Healthcare.

Headlines about PBH stock have been trending very positive this week, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Prestige Consumer Healthcare earned a news impact score of 3.3 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days.
View the latest news about Prestige Consumer Healthcare.

Prestige Consumer Healthcare saw a decline in short interest in February. As of February 15th, there was short interest totaling 7,970,000 shares, a decline of 15.0% from the January 31st total of 9,380,000 shares. Based on an average daily volume of 358,600 shares, the days-to-cover ratio is currently 22.2 days. Currently, 16.0% of the company's shares are short sold.
View Prestige Consumer Healthcare's Short Interest.

Some companies that are related to Prestige Consumer Healthcare include Estee Lauder Companies (EL), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), Medifast (MED), USANA Health Sciences (USNA), Inter Parfums (IPAR), Revlon (REV), Nature's Sunshine Products (NATR) and Veru (VERU).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Prestige Consumer Healthcare investors own include AbbVie (ABBV), Gilead Sciences (GILD), Pfizer (PFE), AT&T (T), Wells Fargo & Co (WFC), IBM (IBM), Intel (INTC), Boeing (BA), Enterprise Products Partners (EPD) and Micron Technology (MU).

Prestige Consumer Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "PBH."

Prestige Consumer Healthcare's stock is owned by many different institutional and retail investors. Top institutional investors include Macquarie Group Ltd. (3.54%), Fisher Asset Management LLC (1.58%), LSV Asset Management (1.43%), Jennison Associates LLC (1.06%), Palisade Capital Management LLC NJ (0.86%) and Russell Investments Group Ltd. (0.84%). Company insiders that own Prestige Consumer Healthcare stock include Paton Brett, Ronald M Lombardi and Timothy Connors.
View institutional ownership trends for Prestige Consumer Healthcare.

PBH stock was sold by a variety of institutional investors in the last quarter, including NN Investment Partners Holdings N.V., NN Investment Partners Holdings N.V., Dalton Greiner Hartman Maher & Co., Skyline Asset Management LP, Dupont Capital Management Corp, Fisher Asset Management LLC, Natixis Advisors L.P., and Cresset Asset Management LLC.
View insider buying and selling activity for Prestige Consumer Healthcare.

PBH stock was purchased by a variety of institutional investors in the last quarter, including UBS Group AG, Macquarie Group Ltd., First Trust Advisors LP, Russell Investments Group Ltd., Mutual of America Capital Management LLC, Duality Advisers LP, Mackay Shields LLC, and Lapides Asset Management LLC.
View insider buying and selling activity for Prestige Consumer Healthcare.

Shares of PBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PBH stock can currently be purchased for approximately $38.16.

Prestige Consumer Healthcare has a market capitalization of $1.92 billion and generates $963.01 million in revenue each year. The company earns $142.28 million in net income (profit) each year or $2.96 on an earnings per share basis. Prestige Consumer Healthcare employs 530 workers across the globe.

The official website for Prestige Consumer Healthcare is www.prestigebrands.com.

Prestige Consumer Healthcare's mailing address is 660 WHITE PLAINS ROAD SUITE 250, TARRYTOWN NY, 10591. The company can be reached via phone at 914-524-6800 or via email at [email protected]